Literature DB >> 32721967

Obesity: An Independent Predictor of Morbidity and Graft Loss after Kidney Transplantation.

Fahad Aziz1, Anand Ramadorai2, Sandesh Parajuli2, Neetika Garg2, Maha Mohamed2, Didier A Mandelbrot2, David P Foley3, Michael Garren4, Arjang Djamali2,3.   

Abstract

BACKGROUND: There is conflicting information on current medical and surgical complications associated with high body mass index (BMI) after kidney transplantation.
METHODS: In a single-center observational study, we analyzed the 5-year outcomes of all consecutive primary kidney transplant recipients between 2010 and 2015 based on BMI at the time of transplant.
RESULTS: There were 1,467 patients included in this study, distributed in the following groups based on BMI: underweight (n = 32, 2.2%), normal (n = 407, 27.7%), overweight (n = 477, 32.5%), grade I obesity (n = 387, 26.4%), grade II obesity (n = 155, 10.6%), and grade III obesity (n = 9, 0.6%). Obesity was associated with an increased incidence of delayed graft function (p = 0.008), length of stay (LOS, p = 0.03), 30-day surgical re-exploration (p = 0.02), and hospital readmission (p < 0.0001). Obesity was also associated with higher 1-year serum creatinine (p = 0.03) and increased 5-year incidence of cardiac events (p < 0.0001) and congestive heart failure (p < 0.0001). Multivariable Cox regression analyses determined grade III obesity (HR = 5.84, 95% CI: 1.40-24.36, p = 0.01), LOS >4 days (HR = 1.94, 95% CI: 1.19-3.18, p = 0.008), hospital readmission (HR = 2.25, 95% CI: 1.20-4.22, p = 0.01), 1-year serum creatinine >1.5 (HR = 1.95, 95% CI: 1.20-3.18, p = 0.007), and proteinuria (UPC) >1 g/g (HR = 1.85, 95% CI: 1.06-3.24, p = 0.03) as independent predictors of death-censored graft failure.
CONCLUSION: In the current era of renal transplant care, obesity is common, and high BMI remains associated with significant medical and surgical complications after transplant.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Body mass index; Cardiac events; Complications; Graft and patient survival

Mesh:

Year:  2020        PMID: 32721967     DOI: 10.1159/000509105

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

1.  Impact of Size Matching Based on Donor-Recipient Height on Kidney Transplant Outcomes.

Authors:  Srijan Tandukar; Christine Wu; Sundaram Hariharan; Chethan Puttarajappa
Journal:  Transpl Int       Date:  2022-03-18       Impact factor: 3.842

2.  Increased macrophage activation marker soluble CD163 is associated with graft dysfunction and metabolic derangements in renal transplant recipients.

Authors:  Hayam El Aggan; Sabah Mahmoud; Heba El Shair; Hazem Elabd
Journal:  Biomed J       Date:  2020-10-01       Impact factor: 7.892

3.  Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA.

Authors:  Gabriel C Oniscu; Daniel Abramowicz; Davide Bolignano; Ilaria Gandolfini; Rachel Hellemans; Umberto Maggiore; Ionut Nistor; Stephen O'Neill; Mehmet Sukru Sever; Muguet Koobasi; Evi V Nagler
Journal:  Nephrol Dial Transplant       Date:  2021-12-24       Impact factor: 5.992

4.  Recipient obesity as a risk factor in kidney transplantation.

Authors:  Sebastian Rademacher; Robert Sucher; Uwe Scheuermann; Jonas Babel; Uta-Carolin Pietsch; Antje Weimann; Orestis Lyros; Katrin Semmling; Hans-Michael Hau; Daniel Seehofer
Journal:  BMC Nephrol       Date:  2022-01-18       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.